Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis
PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
June 30, 2000
Conditions
Systemic Sclerosis
Interventions
DRUG
anti-thymocyte globulin
DRUG
cyclophosphamide
Trial Locations (3)
27710
Duke University Medical Center, Durham
80262
University of Colorado Cancer Center, Denver
98109
Fred Hutchinson Cancer Research Center, Seattle
All Listed Sponsors
lead
Fred Hutchinson Cancer Center
OTHER
NCT00016458 - Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis | Biotech Hunter | Biotech Hunter